Ligand GA: a genetic algorithm for automated protein inhibitor design
Chalmers, G. R.
Show abstract
Ligand GA is introduced in this work and approaches the problem of finding small molecules inhibiting protein functions by using the protein site to find close to optimal or optimal small molecule binders. Genetic algorithms (GA) are an effective means for approximating or solving computationally hard mathematics problems with large search spaces such as this one. The algorithm is designed to include constraints on the generated molecules from ADME restriction, localization in a binding site, specified hydrogen bond requirements, toxicity prevention from multiple proteins, sub-structure restrictions, and database inclusion. This algorithm and work is in the context of computational modeling, ligand design and docking to protein sites.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Streamlining Computational Fragment-Based Drug Discovery through Evolutionary Optimization Informed by Ligand-Based Virtual Prescreening 97%
- Retro Drug Design: From Target Properties to Molecular Structures 96%
- DUBS: A Framework for Developing Directory of Useful Benchmarking Sets for Virtual Screening 96%
Similar papers in this journal
- Deep learning based predictive modeling to screen natural compounds against TNF-alpha for the potential management of Rheumatoid Arthritis: Virtual screening to comprehensive in silico investigation 97%
- Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors 95%
- Identification of Natural Antiviral Drug Candidates Against Tilapia Lake Virus: Computational Drug Design Approaches 95%
Similar papers in this journal
- Target2DeNovoDrugPropMax : a novel programmatic tool incorporating deep learning and in silico methods for automated de novo drug design for any target of interest 97%
- Pharmacophore modeling, 2D-QSAR, Molecular Docking and ADME studies for the discovery of inhibitors of PBP2a in MRSA 97%
- De novo drug designing coupled with brute force screening and structure guided lead optimization gives highly specific inhibitor of METTL3: a potential cure for Acute Myeloid Leukaemia 96%
Similar papers in this journal
- PL-PatchSurfer3: Improved Structure-Based Virtual Screening for Structure Variation Using 3D Zernike Descriptors 96%
- PDBe CCDUtils: an RDKit-based toolkit for handling and analysing small molecules in the Protein Data Bank 95%
- Intuitive, reproducible high-throughput molecular dynamics in Galaxy: a tutorial 94%
Similar papers in this journal
- In Silico Identification of Potential Inhibitors of Mycobacterium tuberculosis DNA Gyrase from Phytoconstituents of Indian Medicinal Plants 96%
- Combining Multi-Dimensional Molecular Fingerprints to Predict hERG Cardiotoxicity of Compounds 95%
- ChAlPred: A Web Server for Prediction of Allergenicity of Chemical Compounds 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.